Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0415-2026

Thermo scientific MAS Omni CARDIO, Liquid Assayed Integrated Cardiac Control Recall

Thermo scientific MAS Omni CARDIO, Liquid Assayed Integrated Cardiac Control, Model/Catalog Number: OCRD-L, OCRD-101, OCRD-202, OCRD-303, OCRD-SP, OCRD-MP, OCRD-UL; Product Description: In Vitro Diagnostic external control

FDA recall Class II

Ongoing

FDA lists this Class II recall for Thermo scientific MAS Omni CARDIO, Liquid Assayed Integrated Cardiac Control. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0415-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Oct 1, 2025
FDA report date
Nov 5, 2025
Quantity in commerce
4462
Distribution
See key details
FDA cause
Nonconforming Material/Component

What is being recalled?

Thermo scientific MAS Omni CARDIO, Liquid Assayed Integrated Cardiac Control, Model/Catalog Number: OCRD-L, OCRD-101, OCRD-202, OCRD-303, OCRD-SP, OCRD-MP, OCRD-UL; Product Description: In Vitro Diagnostic external control

Affected model & UDI checker

Search the exact identifiers published for Z-0415-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
OCRD-101Thermo scientific MAS Omni CARDIO, Liquid Assayed Integrated Cardiac ControlCheck source noticeNot specified
OCRD-202Thermo scientific MAS Omni CARDIO, Liquid Assayed Integrated Cardiac ControlCheck source noticeNot specified
OCRD-303Thermo scientific MAS Omni CARDIO, Liquid Assayed Integrated Cardiac ControlCheck source noticeNot specified
Not specifiedThermo scientific MAS Omni CARDIO, Liquid Assayed Integrated Cardiac ControlCheck source notice00884883011946
Not specifiedThermo scientific MAS Omni CARDIO, Liquid Assayed Integrated Cardiac ControlCheck source notice00884883011953
Not specifiedThermo scientific MAS Omni CARDIO, Liquid Assayed Integrated Cardiac ControlCheck source notice00884883011960
Not specifiedThermo scientific MAS Omni CARDIO, Liquid Assayed Integrated Cardiac ControlCheck source notice00884883011977
Not specifiedThermo scientific MAS Omni CARDIO, Liquid Assayed Integrated Cardiac ControlCheck source notice00884883011984
Not specifiedThermo scientific MAS Omni CARDIO, Liquid Assayed Integrated Cardiac ControlCheck source notice00884883011991
Not specifiedThermo scientific MAS Omni CARDIO, Liquid Assayed Integrated Cardiac ControlCheck source notice00884883012004
FDA code information

OCRD-UL: UDI/DI 00884883011946, Lot Number OCRD2704U, Exp 2027-04-30; OCRD-L: UDI/DI 00884883011953, Lot Number OCRD2704L, Exp 2027-04-30; OCRD-101: UDI/DI 00884883011960, Lot Number OCRD27041, Exp 2027-04-30; OCRD-202: UDI/DI 00884883011977, Lot Number OCRD27042, Exp 2027-04-30; OCRD-303: UDI/DI 00884883011984, Lot Number OCRD27043, Exp 2027-04-30; OCRD-SP: UDI/DI 00884883011991, Lot Number OCRD2704S, Exp 2027-04-30; OCRD-MP: UDI/DI 00884883012004, Lot Number OCRD2704M, Exp 2027-04-30.

View the original FDA recall notice

Why was this product recalled?

The firm received complaints from customers reporting vial-to-vial variability when using the control with high sensitivity Troponin I assays. This defect may lead to as delay in patient results for hs Troponin I assays.

What actions did Microgenics Corporation take?

ThermoFisher Scientific issued an URGENT -MEDICAL DEVICE RECALL notice to its consignees on 10/02/2025 via email. The notice explained the issue, risk to health, and requested the following: "ACTIONS TO BE TAKEN BY A USER 1. If you are a user of the High sensitivity Troponin I Assay, determine if you have inventory of the affected lots of MAS Omni"CARDIO" control as listed in Table 1. As stated in the instructions for use, instrument values provided are specific to this lot of control only and are intended to assist the laboratory in establishing its own means and ranges. 2. You may continue to use controls that meet your laboratory s performance requirements. 3. If the variability of the material exceeds your laboratory s specification, dispose of the material in accordance with local, regional, and national regulations. After disposing of the material, contact [email protected] for a credit. 4. Customers using the affected product with standard/ regular Troponin I assays, can continue to use the product as long as it meets their laboratory s specification and continue monitoring performance of Troponin I in MAS Omni"CARDIO" control. 5. This recall notice needs to be passed to anyone within your organization or any organization where the potentially affected lots have been transferred. 6. Retain a copy of this letter for your laboratory records. 7. Please complete the Recall Response Form attached to this Notification within 10 days of the date of this letter and return to Thermo Fisher as instructed in the form to E-mail:[email protected] 8. If you have any additional questions regarding this Recall Notice, contact Thermo Fisher Scientific Technical Support at toll free 1-800-232-3342 (USA and Canada only) or 510-979-5000 (International), Option 2, then option 3 or by email: [email protected]." "ACTIONS TO BE TAKEN BY A DISTRIBUTOR 1. Please notify your customers of this Recall Notice using this recall notice and request t

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology